Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5
US7253190B2 · kind B2 · utility
5Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2002 |
| Grant date | Aug 7, 2007 |
| Priority date | — |
| Expiry date | May 8, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Tetrazole compounds substituted directly, or by a bridge, with a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, and panic, as well as in the treatment of pain and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.